Home › Osteosarcoma › Rhode Island
Osteosarcoma clinical trials in Rhode Island
3 studies for Osteosarcoma are looking for participants at sites in Rhode Island.
Cities in Rhode Island
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Hasbro Children's Hospital, Providence
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Sep 3, 2026 · NCT06541262Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Rhode Island Hospital, Providence
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT05235165Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Rhode Island Hospital, Providence
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.